Category Archives: BioInformatics

People Exclusive Global Bioinformatics Market Size 2017- BIOVIA, Life Technologies Corporation, Agilent technologies, Celera ... People Exclusive Global Bioinformatics market Report offers decisive insights into the overall Bioinformatics industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various ... Global bioinformatics market expected to hit US$ 12542.4 million by 2020 according to new research reportWhaTech all 2 news articles » Go here to read the rest: Global Bioinformatics Market Size 2017- BIOVIA, Life Technologies Corporation, Agilent technologies, Celera ... - People Exclusive … Continue reading →

Posted June 1, 2017 Atlanta, GA Genetic mitochondrial disease is present in about 1 out of every 5,000 babies, who face insurmountable odds from the moment they are born. Thats because at present, there is no cure for these conditions. But a new assisted reproductive technology that prevents the transmission of mitochondrial disease from mother to child holds great promise. Mitochondrial replacement (MR) therapy combines the nuclear DNA from the mother with healthy mitochondria from a donor egg to create a healthy new egg that can be fertilized with the fathers sperm, thereby yielding a three-person baby. Last year, the worlds first three-person baby resulting from this method was delivered by U.S. doctors in Mexico, where there are no laws prohibiting the procedure. The healthy newborn got about 0.1 percent of his DNA from the donor, and the vast majority of his genetic code specifying eye color, hair, etc. from his mom and dad. Mitochondrial DNA comprises just a small percentage of our total DNA, containing just 37 of the 20,000 to 25,000 protein-coding genes in our body. And while nuclear DNA comes from both parents, our mitochondrial DNA comes directly from our mothers, so my mitochondrial genome will be … Continue reading →

Zoran Brkanac Associate professor, University of Washington Associate professor, University of Washington Most research into the genetic basis of autism focuses on the DNA nestled inside a cells nucleus. Scientists unravel the DNA and study the genes that code for proteins, with the goal of identifying the molecular pathways involved. They then aim to develop treatments that target these pathways. So far, studies have implicated hundreds of nuclear genes in autism, with about 100 genes emerging as strong candidates1,2. But the nucleus may not be the only source of genes involved in autism. DNA also exists inside cellular compartments, or organelles, called mitochondria. These organelles are the powerhouses of cells. They generate a molecule called adenosine triphosphate (ATP), which serves as the main source of cellular energy. Each mitochondrion contains thousands of copies of a circular genome that codes for 13 of the 96 proteins needed to build the mitochondrias core ATP machinery. Unlike nuclear DNA, mitochondrial DNA (mtDNA) is inherited only from the mother. This year, my colleagues and I published results suggesting that variants of mitochondrial genes contribute to autism in some cases, by teaming up with genes in the nucleus. Over the past decade, several lines of … Continue reading →

Project Twins In 2015, geneticist Guy Reeves was trying to configure a free software system called Galaxy to get his bioinformatics projects off the ground. After a day or two of frustration, he asked members of his IT department for help. They installed Docker, a technology for simulating computational environments, which enabled him to use a special version of Galaxy that came packaged with everything he needed called a container. A slight tweak to the Galaxy settings, and he was done before lunch. Reeves, at the Max Planck Institute for Evolutionary Biology in Pln, Germany, is one of many scientists adopting containers. As science becomes ever more data intensive, more software is being written to extract knowledge from those data. But few researchers have the time and computational know-how to make full use of it. Containers, packages of software code and the computational environment to run it, can close that gap. They help researchers to use a wider array of software, accelerate experiments and promote reproducibility. Containers are essentially lightweight, configurable virtual machines simulated versions of an operating system and its hardware, which allow software developers to share their computational environments. Researchers use them to distribute complicated scientific software systems, … Continue reading →

When playing music on iTunes the computing is invisible, and the same should be true when analysing biodata, Dr Misha Kapushesky, CEO of Genestack will argue at Bio-It World Conference & Expo this week. The company has developed a set of easy-to-use tools that allows the collection and aggregation of data across different sources public and internal and then organises, searches, analyses and visualises it without the need for sophisticated programming knowledge. The role of the bioinformatician is disappearing, asserts Dr Kapushesky. For too long we have expected biologists to either learn programming languages like Python, or to use computer analysts, but now we have the tools to make this process invisible and this will free the life scientists to concentrate on interpreting the information. Dr Kapushesky sees the new pain point of drug discovery and genomics as data management: Getting a grasp of the data is difficult. People want to find out where all the data is, both within the organisation and in public repositories, and then figure out what is relevant to their research. Data is created in different ways so you need to understand its provenance and find ways to make it shareable by different R&D groups. … Continue reading →

Genedata, the global market leader in enterprise solutions for data-rich R&D processes, supporting over ten thousand researchers at the world's leading biopharmaceutical companies, will be present at Bio-IT World 2017 Basel, Switzerland (PRWEB) May 23, 2017 Genedata, a leading provider of advanced software solutions for R&D, celebrates this month its 20th anniversary, marking the occasion with a strong presence at Bio-IT World Conference & Expo 2017 in Boston, MA. Genedata is sponsoring the meeting's Welcome Reception and further extends an invitation to all attendees to view posters on the entire range of Genedata software platforms. Conference delegates are also invited to visit the Genedata booth (#238240) at the Expo to discuss the latest developments in the company's rapidly expanding software portfolio. Genedata commenced operations on May 1, 1997 and has grown from a pioneering bioinformatics start-up to a team of more than 200 scientific and computational experts. The company, still headquartered in Basel, Switzerland, has established subsidiaries in the US, Germany, Japan and the UK, with plans to open additional offices around the world in the near future. Genedata has evolved into a global leader in enterprise software systems for biopharmaceutical R&D based on a deep understanding of the underlying … Continue reading →

Bioinformatics involves the development and application of novel informatics techniques in the field of biology. It improves the methods of storing, organizing, retrieving and analyzing biological data. Major activity in bioinformatics is to develop software tools in order to generate useful biological knowledge database. In molecular biology, bioinformatics techniques such as signal processing allow extraction of useful results from large amount of raw data. In the field of genetics it helps in sequencing, annotating genomes and to observe mutations. Bioinformatics study acts a biological literature and developmental data bank for biology related data. View Report @http://www.transparencymarketresearch.com/medical-bioinformatics-market.html Similarly, biomedical informatics is an emerging discipline which defines the study of inventions and implementation of structures, algorithms to improve communication, understanding and managing the medical information. The National Center for Toxicological Research (NCTR) conducts research in bioinformatics and chemo informatics. The bioinformatics tools were created for analysis and integration of genomics, proteomics, metabolomics datasets and transcriptomics. The growth of global medical bioinformatics market is driven by increasing initiatives and funding, use of bioinformatics in drug discovery and biomarkers. The market is expected to offer opportunities with the introduction and adoption of upcoming technologies such as cloud computing and other sequencing technologies. The global … Continue reading →

According to a new market report published by Persistence Market Research Global Market Study on Bioinformatics Asia to Witness Fastest Growth by 2020, the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020. Globally, rising R&D expenditures and rising number of research activities has increased the demand for bioinformatics in the market. As a result, the market is expected to grow at a CAGR of about 20.4% from 2014 2020. Some of the major drivers which help in increasing demand for bioinformatics are growing applications of bioinformatics in drug discovery and development, growing information technology applications in bioinformatics and rising need for integrated bioinformatics systems in proteomics and genomics. Increasing bioinformatics support in the development of personalized medicines and clinical diagnostics also supports the growth of the bioinformatics market. However, lack of skilled and trained professionals and lack of interoperability among data formats are restraining the growth of the bioinformatics market. Rising number of merger and acquisition and new product innovation are some of the latest trends in the bioinformatics market. North America … Continue reading →

May 17, 2017 Credit: MIPT Press Office Researchers from the Vavilov Institute of General Genetics of the Russian Academy of Sciences (VIGG) and the Moscow Institute of Physics and Technology (MIPT) have established a catalog of mutations in 319 virulence genes of mycobacteria that cause tuberculosis. These genes encode proteins that suppress human immune response. Further analysis has identified a set of three mutations which may enable mycobacteria to develop rapidly in an immunocompromised environment. The emerging strains of TB pathogens require new treatment approaches, including the development of new genetically engineered vaccines that take into account both the immune status of a patient and the specific virulence features of a pathogen. The article was published in Genome Biology and Evolution. Lost battle According to the World Health Organization, TB remains one of the most dangerous human infectious diseases, causing over 1.8 million deaths annually. TB is caused by a bacterium known as Mycobacterium tuberculosis or Koch's bacillus. It is clear that HIV-positive individuals and patients with other immunodeficiency conditions are particularly at risk. Additionally, more than 20 percent of TB cases are connected with smoking. TB is no longer a social disease, affecting members of all social strata, a … Continue reading →

Grand View Research, Inc. Market Research And Consulting. According to report published by Grand View Research, Global Bioinformatics Services Market is anticipated to reach USD 4.1 billion by 2024. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period. GlobalBioinformatics Services Marketis anticipated to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period. Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years. Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024. Full Research Report on Global Bioinformatics Services Market: … Continue reading →